Genetic Basis of High-Risk Childhood Cancer Points to Possible New Drug Treatment Strategy

St. Jude Children’s Research Hospital scientists lead a study that finds new genetic defects in high-risk childhood leukemia subtypes with chromosomal loss and evidence that some patients have an inherited cancer syndrome.